Clinical trial
A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of…
NCT00455260 · Teva Neuroscience, Inc., Industry · Completed
Key facts
| NCT number | NCT00455260 |
|---|---|
| Title | A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency |
| Official title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study, to Assess Tolerability, Safety, Pharmacokinetic and Pharmacodynamic Profiles of hGH-ViaDerm™ System in Adult Subjects With Growth Hormone Deficiency |
| Lead sponsor | Teva Neuroscience, Inc., Industry |
| Collaborators | Teva Branded Pharmaceutical Products R&D, Inc. Industry TransPharma Medical |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Growth Hormone Deficiency |
| Intervention type | Device, Drug |
| Interventions | hGH-ViaDerm™ System (hGH or somatropin), hGH-ViaDerm™ System |
| Enrollment | 60 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2007 |
| First posted | Apr 3, 2007 |
| Last update posted | Sep 2, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: